MEAGAN MALEK: Open Payments
NPI 1487158432 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 83 payments from 16 companies in 2025. Trend: 2023 $702 · 2024 $927 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $333 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $195 |
| Lundbeck LLC | 14 | $171 |
| Indivior Inc. | 4 | $85 |
| PFIZER INC. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Alkermes, Inc. | 3 | $45 |
| Corium, LLC | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, REXULTI, SUBLOCADE, NURTEC ODT, Auvelity, QULIPTA, ARISTADA.
Industry payments across IN — which companies pay providers there.
